Page last updated: 2024-08-24

imiquimod and Diabetes Mellitus, Type 2

imiquimod has been researched along with Diabetes Mellitus, Type 2 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's5 (100.00)2.80

Authors

AuthorsStudies
Jun, L; Kun, X; Lu, L; Pin, C; Wei, C; Xiangjin, X; Xiaohong, L; Xin, L; Yunjie, Y; Zhenting, Z1
Chen, P; Li, X; Shao, Z; Xu, X1
Christman, MA; McKinzie, AH1
An, Q; Du, G; Hao, Y; Li, W; Lu, Y; Ren, L; Wang, J; Yang, D; Yang, H; Yang, Y; Yu, M; Zhang, S; Zhang, Y1
Brain, SD; Caton, PW; Evans, EA; Frame, J; Hannen, RF; Kodji, X; Philpott, MP; Rizvi, A; Sayers, SR; Shaikh, M; Xia, Y1

Other Studies

5 other study(ies) available for imiquimod and Diabetes Mellitus, Type 2

ArticleYear
Activation of the STING-IRF3 pathway involved in psoriasis with diabetes mellitus.
    Journal of cellular and molecular medicine, 2022, Volume: 26, Issue:8

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Humans; Imiquimod; Interferon Regulatory Factor-3; Mice; Psoriasis

2022
DPP-4 inhibitor linagliptin ameliorates imiquimod-induced psoriasis-like skin alterations in type 2 diabetic mice by inhibiting the MAPK/NF-κB inflammatory pathway.
    Drug development research, 2022, Volume: 83, Issue:6

    Topics: Animals; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Hypoglycemic Agents; Imiquimod; Insulin Resistance; Interleukin-23; Linagliptin; Mice; NF-kappa B; Psoriasis; Tumor Necrosis Factor-alpha

2022
Imiquimod-Associated Localized Skin Ulceration in a Patient With Uncontrolled Diabetes.
    Obstetrics and gynecology, 2022, 08-01, Volume: 140, Issue:2

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Diabetes Mellitus, Type 2; Humans; Imiquimod

2022
Design, synthesis and characterization of a novel multicomponent salt of bexarotene with metformin and application in ameliorating psoriasis with T2DM.
    International journal of pharmaceutics, 2023, Nov-05, Volume: 646

    Topics: Animals; Bexarotene; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Imiquimod; Metformin; Mice; Psoriasis; Sodium Chloride; Tetrahydronaphthalenes

2023
Psoriatic skin inflammation induces a pre-diabetic phenotype via the endocrine actions of skin secretome.
    Molecular metabolism, 2020, Volume: 41

    Topics: Animals; Cell Proliferation; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Humans; Imiquimod; Inflammation; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Prediabetic State; Psoriasis; Skin

2020